↓ Skip to main content

Effects of sitagliptin beyond glycemic control: focus on quality of life

Overview of attention for article published in Cardiovascular Diabetology, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
11 X users
facebook
1 Facebook page

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of sitagliptin beyond glycemic control: focus on quality of life
Published in
Cardiovascular Diabetology, February 2013
DOI 10.1186/1475-2840-12-35
Pubmed ID
Authors

Yoshiko Sakamoto, Jun-ichi Oyama, Hideo Ikeda, Shigetaka Kuroki, Shigeki Gondo, Taketo Iwamoto, Yasufumi Uchida, Kazuhisa Kodama, Atsushi Hiwatashi, Mitsuhiro Shimomura, Isao Taguchi, Teruo Inoue, Koichi Node, S-DOG [Saga Challenge Anti-Diabetes Observational Study for Sitagliptin (S-DOG)] investigators

Abstract

Recently, incretin hormones, including glucagon-like peptide-1 (GLP-1) analogue and dipeptidyl peptidase-4 (DPP-4) inhibitor, have been found to regulate glucose metabolism. The aim of this study was to elucidate the efficacy and safety of the clinical usage of DPP-4 inhibitors in Japan.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
India 1 <1%
Denmark 1 <1%
China 1 <1%
Japan 1 <1%
Unknown 116 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 17%
Researcher 16 13%
Student > Ph. D. Student 16 13%
Student > Bachelor 11 9%
Student > Doctoral Student 6 5%
Other 18 15%
Unknown 34 28%
Readers by discipline Count As %
Medicine and Dentistry 49 40%
Nursing and Health Professions 10 8%
Agricultural and Biological Sciences 7 6%
Sports and Recreations 3 2%
Social Sciences 3 2%
Other 12 10%
Unknown 37 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2019.
All research outputs
#4,887,433
of 25,736,439 outputs
Outputs from Cardiovascular Diabetology
#391
of 1,689 outputs
Outputs of similar age
#38,213
of 205,783 outputs
Outputs of similar age from Cardiovascular Diabetology
#5
of 32 outputs
Altmetric has tracked 25,736,439 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,689 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,783 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.